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Kallikrein-Related Peptidase 8–Dependent Skin
Wound Healing Is Associated with Upregulation
of Kallikrein-Related Peptidase 6 and PAR2
Mari Kishibe1, Yoshio Bando2, Tatsuhide Tanaka2, Akemi Ishida-Yamamoto1, Hajime Iizuka1 and
Shigetaka Yoshida2
Kallikrein-related peptidase 8 (KLK8) is believed to be involved in the maintenance of skin homeostasis and
pathogenesis of inflammatory skin diseases. Although previous studies have shown that KLK8 is expressed
around incisional wounds, the exact role of KLK8 in wound healing remains obscure. In the present study, we
compared wound healing in wild-type (WT) and Klk8 gene–disrupted (kallikrein-related peptidase 8 knockout,
Klk8/) mouse skin. Wound healing in Klk8/ mice was hampered with defective keratinocyte proliferation,
differentiation, and migration in the early stages of wound healing. Compared with the prominent induction of
Klk6 and protease-activated receptor 2 (PAR2) messenger RNA, and protein in WTmice after wounding, a much
lower increase was observed in Klk8/ skin. After skin wounding in WTmice, increased Klk6 was detected from
the upper stratum spinosum to the stratum corneum. Moreover, in WTmice, Klk6 protein was processed. PAR2
was diffusely expressed in the cytoplasm of the stratum spinosum at day 7 post wounding in WT mice. These
results suggest that Klk8 is involved in the proliferation and migration of keratinocytes through the upregulation
and activation of Klk6 in the early stages of wound healing, and possibly in keratinocyte differentiation
associated with the upregulation and activation of PAR2 in the late stages of wound healing.
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INTRODUCTION
Several proteases of the kallikrein family are expressed
in the epidermis and are involved in the maintenance of
structural integrity and barrier function of the epidermis.
Aberrations in human tissue kallikrein (KLK) activity have
been detected in the skin diseases characterized by an
abnormal epidermal barrier such as atopic dermatitis
(Komatsu et al., 2007).
KLKs comprise a subgroup of 15 serine proteases encoded
by a tightly clustered multigene family on chromosome
19q13.4 (Evans et al., 1987; Yousef et al., 2000). This region
is also synthenic to the locus on mouse chromosome 7 where
the mouse kallikrein gene family cluster is localized (Evans
et al., 1987; Yoshida et al., 2000), with mouse serine proteases
sharing a high degree of sequence and structural similarity
with human homologs (Evans et al., 1987; Yousef et al.,
2000). According to the current nomenclature, KLK1 is a
tissue kallikrein, and the other 14 KLKs are kallikrein-related
peptidases. The importance of KLKs in the skin is implicated
by the complex mechanisms that regulate KLKs in the
epidermis. KLKs, including KLK7 and KLK8, are transported
by lamellar granules and secreted into intercellular spaces
between the stratum granulosum and stratum corneum
(Ishida-Yamamoto et al., 2004), followed by activation via
an activation cascade (Eissa and Diamandis, 2008). KLK5 is
believed to initiate the cascade reaction by autoactivation
and activation of KLK7 and KLK14; the latter then activates
KLK5, creating a positive feedback loop (Emami and
Diamandis, 2008). KLK5 and KLK7 can proteolyze corneo-
desmosomal proteins, leading to corneocyte shedding (Caubet
et al., 2004). Other KLKs involved in the proteolysis of cor-
neodesmosomes include KLK1, KLK6, and KLK14, which
cleave desmoglein 1 (Borgono et al., 2007). Importantly, KLKs
can activate protease-activated receptors (PARs; Oikonomo-
poulou et al., 2006; Stefansson et al., 2008).
Human KLK8 was originally cloned from skin cDNA as the
homolog of mouse Klk8/neuropsin (Klk8). Its cDNA and
predicted amino-acid sequence have 72% identity to mouse
neuropsin, and key amino-acid residues for enzyme activity
are conserved between humans and mice (Yoshida et al.,
1998). Among the trypsin-like KLKs, KLK8 is the most abundant
in the stratum corneum and sweat (Komatsu et al., 2006).
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Previous reports suggest that KLK8 is upregulated in inflam-
matory skin diseases and wound healing (Kitayoshi et al.,
1999; Komatsu et al., 2007). Furthermore, our previous study
suggests that Klk8 is also involved in desquamation in 12-O-
tetradecanoyl-phorbol acetate–exposed skin through cleavage
of desmoglein 1 and corneodesmosin, possibly in coopera-
tion with other Klks (Kishibe et al., 2007). Recently, Eissa
et al. (2011) reported that KLK8, activated by KLK5, can
process pro-KLK1 and pro-KLK11 in vitro. The role of KLK8 in
the activation cascade and its function in vivo remains to be
fully elucidated.
PARs are G-protein-coupled, seven transmembrane–spanning
membrane receptors present in many cell types including
keratinocytes (Dery et al., 1998). PARs are activated by
cleavage of the extracellular N-terminal domain of the
receptor, releasing a small peptide that activates the receptor
as a tethered ligand. The activation of PAR2 by KLKs in
keratinocytes has received much attention. PAR2 has been
implicated in the regulation of keratinocyte proliferation and
differentiation (Derian et al., 1997; Macfarlane et al., 2005),
epidermal barrier homeostasis (Hachem et al., 2006), and
inflammation (Briot et al., 2010). KLK5, KLK6, and KLK14,
but neither KLK7 nor KLK8, activate PAR2 in vitro (Oikono-
mopoulou et al., 2006; Stefansson et al., 2008). Gene mutation
of the serine protease inhibitor Kazal-type 5 (SPINK5) causes
hyperactivity of KLK5, resulting in excessive desquamation,
upregulation, and activation of PAR2, and induction of various
inflammatory cytokines (Briot et al., 2009). Therefore, methods
that control KLK-induced PAR2 signaling might offer new
therapeutic strategies for the skin barrier dysfunction and
inflammatory skin diseases.
To elucidate the physiological functions of KLK8 in
the skin, we analyzed wound healing in kallikrein-related
peptidase 8 knockout (Klk8/) mice and found that it was
significantly delayed and was associated with upregulation of
other Klks and marked inhibition of PAR2.
RESULTS
Klk8 mRNA and protein were upregulated after skin wounding
We first investigated Klk8 messenger RNA (mRNA) expres-
sion during skin wound healing. Although relatively weak
expression of the Klk8 gene was detected before wounding, it
was markedly induced after wounding (Figure 1a). Quanti-
tative reverse transcriptase–PCR (RT-PCR) also revealed that
Klk8 mRNA was upregulated from days 1–14 post wounding,
peaking at day 7. The maximal level was 11-fold greater than
that before wounding (Figure 1b). Klk8 immunoreactivity was
weak in the stratum granulosum at day 1 post wounding, but
became markedly intense in the region from the lower
stratum spinosum to the stratum corneum in the proliferating
epidermis until day 7 (Figure 1c-f).
Wound healing in Klk8/ mice was significantly delayed
compared with WT mice
To assess the role of Klk8 in wound healing in vivo, we
measured wound sizes daily until complete epithelialization
in wild-type (WT) and Klk8/ mice. Macroscopically,
wound sizes were larger in Klk8/ mice (Figure 2a). Daily
measurements revealed a significant difference in wound
sizes between the two genotypes from day 3 to day 11 post
wounding (Figure 2c). In addition, the wound closure time
of Klk8/ mice was significantly longer than that of WT
mice (14.5±1.8 days vs. 13.0±1.2 days, Po0.05). Figure 2b
shows representative micrographs of wounded skin at day 7
post wounding, showing a larger wound gap in Klk8/ mice
compared with WT mice. These findings suggest that Klk8
gene deletion delays wound healing.
Impact of Klk8 deletion on wound healing
Wound healing is a complex event involving the coordina-
tion of epidermal proliferation, migration, differentiation,
and angiogenesis. We compared these changes in WT and
Klk8/ skin. Microscopic observation revealed that the re-
epithelialized epidermis was grossly thicker in WT mice than
in Klk8/mice from days 3 to 7 post wounding (Figure 3a, b,
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Figure 1. Expression of Klk8 messenger RNA (mRNA) in skin wounds of
wild-type (WT) and Klk8/ mice. (a) Klk8 mRNA in the wounded skin of WT
and Klk8/ mice. (b) Real-time reverse transcriptase–PCR (RT-PCR) analysis
of Klk8 mRNA expression in the wounded skin of WT mice (n¼ 6). Data are
presented as mean±SEM. *Po0.05, **Po0.01 indicate significant difference
from day 0. Immunohistochemistry for Klk8 (red) with 40, 6-diamino-2-
phenylindole (DAPI) staining (blue) at days (c) 1, (d) 3, (e) 5, and (f) 7 post
wounding in the WT mice. The dermoepidermal junction is demarcated
by dotted lines. Asterisks demarcate the migrating wound edge. Bars¼ 50 mm.
DAPI, 40, 6-diamino-2-phenylindole; DAY, post-wounding day; b2-MG,
b2-microglobulin.
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d, and e), and this was confirmed by the measurements
taken at days 3 and 5 post wounding (Figure 3g). Closer
examination of the stratum granulosum of the re-epitheli-
alized epidermis in Klk8/ mice at day 7 showed increased
cellular volume, with cells containing coarse and abundant
keratohyaline granules; this feature was seen only in a single
layer of cells in the skin of WT mice (Figure 3 b, c, e, and f,
arrows). The stratum granulosum in Klk8/ mice was
significantly thicker than in WT mice (97.0±12.3 mm vs.
37.1±7.7 mm, n¼ 5, Po0.01). These findings suggest slower
keratinocyte differentiation in Klk8/ mice. We also mea-
sured the distance between the migrating epidermal tip and
the original wound edge. The length of the migrating epidermis
of WT mice was greater than that of Klk8/ mice at day
3 post wounding, but no significant difference was observed
at day 5 (Figure 3h).
We next compared the number of Ki-67-positive cells after
wounding to assess keratinocyte proliferation in WT and
Klk8/ mice (Figure 3i). In WT mice, the number of Ki-67-
positive cells was increased, with a peak observed 3 days
after wounding. However, the increase in Ki-67-positive cells
was delayed in Klk8/ mice with a peak observed 5 days
after wounding. WT skin showed significantly more Ki-67-
positive cells at days 1 and 3 post wounding. These results
suggest that Klk8 is involved in the proliferation and mig-
ration of keratinocytes at the early stages of wound healing.
The delayed re-epithelialization in Klk8/ mice might be a
result of decreased keratinocyte proliferation.
The number of CD31-positive vessels, indicative of angio-
genesis, was not significantly different between WT and
Klk8/ mice (Figure 3j).
The expression of activating protein-2a (AP-2a) mRNA,
which is inhibited by KLK8 (Shingaki et al., 2010), was more
suppressed until day 1 post wounding and was more
upregulated after day 3 in WT mice, although there was no
statistical significance (Supplementary Figure S1 online).
In addition, AP-2a protein was more abundant in WT at
day 5.
Inflammatory cytokines including tumor necrosis factor-a,
IL-1b, IL-6, and hepatocyte growth factor (HGF), and c-Met
receptor, which is activated by HGF (Yoshida et al., 2003),
were compared between two genotypes (Supplementary
Figure S2 online). Tumor necrosis factor-a, IL-1b, and c-Met
mRNA in WT were significantly more upregulated than that
in Klk8/ mice at day 1 post wounding. IL-6 mRNA was
significantly increased in WT at day 1, although there was no
significant difference between genotypes. HGF in WT mice
was significantly increased; however, its expression level in
WT was lower at day 3 post wounding and higher than that in
Klk8/ at days 5 and 7.
Changes in the expression of Klk6 mRNA and their products in
WT and Klk8/ skin after wounding
As Klks function in a cascade reaction involving multiple
members, we investigated the expression of Klk6 and Klk7 in
WT and Klk8/ epidermis after skin wounding. Quantitative
RT-PCR revealed that Klk6 mRNA was increased in both
genotypes post wounding relative to day 0, with significantly
greater upregulation in WT mice (Figure 4a). Klk6 mRNA was
increased up to 40-fold in WT mice, with the peak at 3 days
after wounding, whereas the skin of Klk8/ mice showed
only a 20-fold increase with the peak at day 1. Klk7 mRNA
was upregulated 5-fold at 5 days after skin wounding in
WT mice, and increased Klk7 mRNA expression was also
observed in Klk8/ skin, but this was not statistically sig-
nificant (Supplementary Figure S3 online). These results
suggest that Klk8 is involved in the induction of Klk6 (and
perhaps Klk7) mRNA after skin wounding.
We next investigated the expression of Klk6 proteins in
wounded mice skin. Immunohistochemistry revealed that
Klk6 was weak in the epidermis, but was prominent in the
hair follicles in both genotypes before wounding (data not
shown). After skin wounding, Klk6 increased steadily in the
upper stratum spinosum and stratum corneum in WT mice
until day 3 post wounding (Figure 4b, d, and h), after which
expression subsided but remained detectable at day 7
(Figure 4f and j). Colocalization of Klk8 and Klk6 was
observed on the cell surface or in the intercellular spaces of
the stratum spinosum and stratum corneum at day 7
post wounding in WT mice (Figure 4f and j). In contrast,
Klk6 expression in Klk8/ mice was confined to the thin
layers of the upper epidermis after wounding (Figure 4c,
e, g, i, and k).
Western blot analysis detected a greater increase in Klk6
expression in WT mice than in Klk8/ mice during wound
healing (Figure 4l). Molecular sizes of Klk6 in WT appeared
smaller than those in Klk8/ mice, suggesting processing of
Klk6 after wounding in WT skin.
Changes in the expression of PAR2 mRNA and its products in
WT and Klk8/ skin after wounding
As Klk6 could directly activate PAR2 (Oikonomopoulou
et al., 2006), we investigated the expression of PAR2 in the
wounded skin of WT and Klk8/ mice. Although PAR2
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Figure 2. Delay in cutaneous wound healing in Klk8/ mice.
(a) Representative appearance of wounds at day 5. (b) Hematoxylin and
eosin (H&E) staining of wounded skin at day 7 post wounding. Arrows
demarcate the wound margins. Bars¼ 300mm. (c) Maximum length
of the wound in wild-type (WT; open circles) and Klk8/ mice (filled circles)
post wounding (n¼ 12, for each time point and group). Data are presented
as mean±SEM. *Po0.05, **Po0.01.
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mRNA was increased after wounding in both genotypes
(Figure 5a), the increase of PAR2 mRNA in WT skin was
markedly more compared with Klk8/ skin. Immunohisto-
chemistry showed that PAR2 was weak and confined to the
granular layer at day 1 post wounding (Figure 5b and c), but
steadily increased in the proliferating epidermis until day 7 in
both genotypes (Figure 5d–g). At days 3 and 7 post wounding,
membranous PAR2 immunoreactivity was detected in the
stratum granulosum and was diffuse in the cytoplasm in the
lower stratum spinosum in WT mice (Figure 5h and j). In
contrast, in Klk8/ mice, PAR2 was localized on the cell
membrane in the stratum granulosum (Figure 5i, and k).
As PAR2 is internalized following its activation by ligand
proteases (Ossovskaya and Bunnett, 2004), our results suggest
that PAR2 was more induced and activated in WT than in
Klk8/ mice.
DISCUSSION
In this study, skin wound healing was delayed in Klk8/
mice, suggesting an important role of Klk8 in this process.
Previous studies showed that KLK8 was expressed around the
incisional wound made in the central nervous system
(Tomizawa et al., 1999) and in the human and mouse skin
(Kitayoshi et al., 1999; Kuwae et al., 2002). Consistent with
these findings, we observed an increase in Klk8 mRNA, as
well as an increase in Klk8 protein in the stratum spinosum
and corneum of the proliferating epidermis, but not in the
migrating tip, after wounding (Figure 1). Kitayoshi et al.
(1999) also reported that Klk8 was not expressed in the
migrating wound tip during re-epithelialization, suggesting
that Klk8 might accelerate differentiation rather than affect
proliferation or migration of keratinocytes. Keratinocytes in
the wounded margins begin to proliferate behind the actively
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Figure 3. Histopathological examination of skin wounds in (wild-type) WT and Klk8/ mice. (a–f) Hematoxylin and eosin (H&E) staining of wounded skin.
Panels c and f are higher magnification of boxed areas in b and e, respectively. Arrows indicate stratum granulosum keratinocytes containing coarse and
abundant keratohyaline granules. Asterisks indicate migrating wound tips. Bar¼ 50 mm. DAY, post-wounding day. (g) Thickness of the re-epithelialized
epidermis of WT (white bar; n¼6) and Klk8/ mice (black bar; n45) after wounding. (h) The distance from the original wound site to the migrating wound tip
in WT (white bar; n¼ 7) and Klk8/ mice (black bar; n¼ 7). (i) Changes in the number of Ki-67-positive keratinocytes of WT (white bars; n¼ 4) and Klk8/
mice (black bars; n¼ 4) after wounding. (j) The number of CD31-positive vessels within a 1-mm2 area from the migrating wound tip. Data are presented as
mean±SEM. (g, h) * And ** indicate a significant difference from day 3 post wounding or (i) from the day without wounds (Po0.05 and Po0.01, respectively);
# and ## indicate a significant difference between the two genotypes (Po0.05 and Po0.01, respectively).
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migrating region during days 1–2 post injury (Singer and
Clark, 1999). In the present study, keratinocyte proliferation
was significantly increased in WT mice compared with
Klk8/ mice in the relatively early stages of wound healing
(1–3 days post wounding), suggesting an involvement of Klk8
in epidermal proliferation. A recent study indicated that KLK8
inhibits expression of the transcription factor, AP-2a (Shingaki
et al., 2010), which is involved in terminal differentiation and
the loss of AP-2a representing hyperproliferation (Wang
et al., 2006). Our findings (Supplementary Figure S1 online),
combined with these reports, suggest that Klk8 may accel-
erate keratinocyte proliferation in the early stages of wound
healing, and differentiation in the late stage of wound
healing. We also found that upregulation of tumor necrosis
factor-a and IL-1b, which is important for normal wound
healing (Hubner et al., 1996), was suppressed in Klk8/
mice (Supplementary Figure S2 online), suggesting that Klk8
promotes normal wound healing associated with inflamma-
tory cytokines.
Hypergranulosis (thickening of the stratum granulosum)
was observed in the migrating epidermis in Klk8/ mice at
day 7 post wounding (Figure 3e and f), possibly because of
accelerated differentiation of keratinocytes in the stratum
spinosum and/or slow transformation of granular keratino-
cytes into corneocytes in the re-epithelialized epidermis.
Previously, we reported that Klk8 is involved in corneocyte
shedding through cleavage of desmoglein 1 and corneodes-
mosin in association with other Klks, including Klk6 (Kishibe
et al. 2007). These data suggest that Klk8 may have an
important role in regulating epidermal differentiation. Inter-
estingly, the level of keratinocyte proliferation and migration
in Klk8/mice appear to approach that of WT mice after day
5 post-wounding (Figure 3g–i). The reduction in wound size
appeared to also follow this trend; wounds in Klk8/ mice
were larger in the early days after wounding, but their size
approached that of WT mice after day 7 (Figure 2c). These obser-
vations suggest that compensatory mechanisms such as activation
of other proteases exist at later stages of wound healing.
As the cascade reaction of KLKs influences the various
functions of KLKs, we investigated the relationship between
Klk8 and other Klks in wound healing (Caubet et al., 2004;
Brattsand et al., 2005). KLK5 is believed to be the initiator of
the activation cascade (Caubet et al., 2004; Brattsand et al.,
2005); however, we were unable to detect Klk5 in this study,
possibly because of its low expression in mouse skin. As was
seen in our previous 12-O-tetradecanoyl-phorbol acetate–
application study (Kishibe et al. 2007), Klk8 mRNA was
upregulated in parallel with Klk6 and Klk7 mRNA (Figure 4a
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Figure 4. Expression of Klk6 after wounding in wild-type (WT) and Klk8/
mice. (a) Real-time PCR of Klk6 mRNA. White bars, WT mice (n45).
Black bars, Klk8/ mice (n45). Data are presented as mean±SEM.
* And ** indicate a significant difference compared with day 0 (Po0.05 and
Po0.01, respectively); # and ## indicate a significant difference between
the two genotypes (Po0.05 and Po0.01, respectively). (b–k) Expression
of Klk6 (green) and Klk8 (red) at (b, c) days 1, (d, e) 3, and (f, g) 7 after
wounding in WT (left panels) and Klk8/ mice (right panels). h, i, j, and k are
magnified images of the boxed insets in d, e, f, and g, respectively, with DAPI
staining (blue). Asterisks indicate the direction of the migrating wound tip.
The dermoepidermal junction is demarcated by the dotted lines. (b–g)
Bars¼ 50 mm or (h–k) 20mm. DAY, post-wounding day; DAPI, 40, 6-diamino-
2-phenylindole. (l) Western blot analysis of Klk6 proteins in WT and
Klk8/ mice after wounding.
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and Supplementary Figure S3 online), suggesting that these
enzymes function in the activation cascade. The expression
of Klk7 was not significantly different between the two
genotypes, whereas Klk6 mRNA was upregulated to a
greater degree in WT mice. These findings suggest a close
relationship between Klk8 and Klk6, as was observed in the
epidermis after 12-O-tetradecanoyl-phorbol acetate treat-
ment, but the mechanism of Klk6 and Klk8 mRNA upregula-
tion remains unknown. As Klk8 transfection of Klk8/
keratinocytes did not induce Klk6 mRNA expression in our
previous study (Kishibe et al. 2007), Klk8 itself does not seem
to be involved in the transcriptional regulation of Klk6, at
least in vitro. Western blot analysis revealed that the 27.5-
kDa Klk6 was detected in WT mice, whereas the 28.2-kDa
Klk6 was detected in Klk8/ mice. This 0.7 kDa difference
between two genotypes is consistent with the size of
processed pro-sequence. Therefore, we speculate that Klk8
can activate Klk6 either directly or indirectly. During
cutaneous wound healing, the keratinocytes of Klk6 trans-
genic mice showed increased proliferation and migration
associated with reduced E-cadherin protein compared with
control littermates (Klucky et al., 2007). Similarly, the
differences in keratinocyte migration and proliferation in
the early stages of wound healing in this study may be
influenced by Klk6.
Evidence of the involvement of PAR2 in wound healing,
cutaneous inflammatory diseases, and epidermal barrier
homeostasis is accumulating (Hachem et al., 2006; Briot
et al., 2009). In the present study, we found a close
relationship between PAR2, and Klk8 and Klk6 proteases.
First, the induction of PAR2 expression after wounding was
more marked in WT than Klk8/ mice (Figure 5), suggesting
that Klk8 may directly or indirectly induce PAR2. Second,
PAR2 was expressed in the cytosol of keratinocytes in the
stratum spinosum (Figure 5h and j). At the same time, Klk6
and Klk8 were localized in the intercellular spaces of the
stratum spinosum and stratum granulosum (Figure 4h and j).
Although Klk8 could not directly induce or activate PAR2,
Klk8 may be involved in the activation of PAR2 via Klk6.
PAR2 is thought to have a role in the terminal differentiation
of keratinocytes based on the observation that cornification
after acute skin barrier disruption was delayed in PAR2/
mice (Demerjian et al., 2008; Roelandt et al., 2011). Possibly,
Klk8 has a role in the switch between epidermal cell
proliferation and differentiation through upregulation and
activation of PAR2 at the late stages of wound healing, but
the mechanism by which Klk8 modulates Klks-PAR2 signal-
ing remains to be determined.
In conclusion, we showed that Klk8 is involved in wound
healing associated with upregulation and activation of Klk6,
and inducing keratinocyte differentiation possibly related to
the upregulation of PAR2, although the mechanism of Klk6
and PAR2 upregulation remains to be determined. We
propose that Klk8 regulates the balance between keratinocyte
proliferation and differentiation in response to skin injury,
and further understanding of its role in wound healing may
reveal new therapeutic strategies in this area.
MATERIALS AND METHODS
Mice and wound healing model
All experiments were conducted with Klk8/ mice with C57BL/6
genetic background (Hirata et al., 2001) and WT C57BL/6 mice. All
experimental protocols were carried out according to protocols
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Figure 5. PAR2 expression after wounding in wild-type (WT) and Klk8/
mice. (a) Reverse transcriptase–PCR (RT-PCR) analysis of proteinase-activated
receptor 2 (PAR2) mRNA expression in the wounded skin of WT and Klk8/
mice. (b–k) Expression of PAR2 (green) at (b, c) days 1, (d, e) 3, and (f, g) 7 post
wounding in WT (left panels) and Klk8/ mice (right panels). h, i, j, and k are
magnified images of the boxed insets in d, e, f, and g, respectively. The
asterisks indicate the direction of the migrating wound tip. Arrows indicate
cytoplasmic staining for PAR2. The dermoepidermal junction is demarcated
by dotted lines. (b–g) Bars¼ 50mm or (h, k) 20 mm. DAY, post-wounding day,
b2-MG, b2-microglobulin; PAR2, proteinase-activated receptor 2.
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approved by the Institutional Animal Care and Use Committee of
Asahikawa Medical University. Full-thickness, 8-mm punch biopsies
were made on the shaved and depilated back of 8–12-week-old
female WT and Klk8/ mice. Wounds were left uncovered and
harvested in its entirety along with a 5-mm margin at days 1, 3, 5, 7,
and 14 post wounding. Specimens were frozen in liquid nitrogen
and stored at 80 1C until use. In some mice, the maximum length of
the wound was measured daily until complete epithelialization was
achieved.
Reverse transcriptase–PCR
Total RNA was isolated according to the protocol of the RNeasy
Fibrous Tissue Mini Kit (Qiagen, Valencia, CA) for RT-PCR. A mea-
sure of 2mg of total RNA was reverse transcribed with AMV reverse
transcriptase (Promega, Madison, WI), and PCR was performed using
the HotstarTaq DNA polymerase kit (Qiagen). Real-time quantitative
PCR was performed following the protocol described in the Light
cycler 480 SYBR I Master kit (Roche Diagnostic, Manheim, Germany),
or Universal PCR master mix (Applied Biosystems, Foster City, CA).
The primers and probe are listed in Supplementary Table S1 online.
Results were represented using a standard curve for comparison or
delta Ct method.
Histological observation
The wounded skin was fixed in 20% formalin and embedded in
paraffin. Paraffin sections were stained with hematoxylin and eosin.
For immunohistochemistry, 6-mm-thick frozen sections were
incubated with primary antibody for 1 h at room temperature.
Primary antibodies are listed in Supplementary Table S2 online.
Primary antibody was detected using an FITC-conjugated or a
peroxidase-conjugated secondary antibody. Vectastain Elite ABC Kit
(Vector Laboratories, Burlingame, CA) was used for the detection of
peroxidase. Additional information regarding the method of mea-
surement for various factors is indicated in the Supplementary
Material and Method online.
Western blotting
The incised mouse skin was incubated in 1M NaCl at 4 1C for
72 hours. The epidermis was mechanically separated from the
dermis and homogenized in a sample buffer containing 62.5mM
Tris-HCl, 2% glycerol, 1% SDS, 5mM EDTA, 1mM phenylmethyl-
sulfonyl fluoride, and a protease inhibitor cocktail (Sigma, Saint
Louis, MO), and centrifuged at 15,000g for 20minutes at 4 1C. The
supernatant was used as the epidermal extract. Proteins of the
epidermal extract were separated by Novex Tris-Glycine gel
(Invitrogen, Carlsbad, CA) SDS-PAGE and blotted onto polyvinyli-
dene difluoride membranes (Millipore, Billerica, MA). The mem-
branes were incubated with primary antibodies. Primary antibodies
are listed in Supplementary Table S2 online. The final detection was
performed with 1:2000 dilutions of horseradish peroxidase–conju-
gated secondary antibodies and visualized using the ECL Advance
Western Blotting Detection Kit (GE Healthcare UK, Buckingham-
shire, UK), and detected by chemiluminescence using LAS-3000
Luminescent Image Analyzer (Fujifilm, Tokyo, Japan).
Statistical analysis
Student’s t-test was used for statistical analysis. Po0.05 was con-
sidered statistically significant. Data are presented as mean±SEM.
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